Noninfectious Uveitis clinical trials

Explore recruiting noninfectious uveitis clinical trials.

Also recruiting in Europe

Noninfectious Uveitis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 1/2a Study of REGN7041 (anti-CD3 monoclonal antibody) in patients with Active Noninfectious Uveitis affecting the Posterior Segment

France

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Evaluation of a therapeutic de-eScalation strategy based on therapeutic drug MOnitOring in chronic non-infectious uveitis Treated witH adalimumab

France

Therapeutic use (Phase IV) EU CTIS Study details

Noninfectious Uveitis trials by city

Noninfectious Uveitis in Toronto Noninfectious Uveitis in Vancouver Noninfectious Uveitis in Montreal Noninfectious Uveitis in Calgary Noninfectious Uveitis in Edmonton Noninfectious Uveitis in Ottawa Noninfectious Uveitis in Winnipeg Noninfectious Uveitis in Quebec City Noninfectious Uveitis in Hamilton Noninfectious Uveitis in Kitchener Noninfectious Uveitis in London Noninfectious Uveitis in Halifax Noninfectious Uveitis in New York Noninfectious Uveitis in Los Angeles Noninfectious Uveitis in Chicago Noninfectious Uveitis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease